EBV Nuclear Antigen Antibody IgM

EBV contributes to more than 30 autoimmune disorders. Detection of IgG or IgM antibodies to various EBV antigens indicates either past infection, primary reactivation, or re-infection with Epstein-Barr Virus or Herpes Type 4.

The Long COVID Panel is used to detect three major viruses (EBV, HHV-6, and SARS-CoV-2) associated with long COVID and autoimmunity. It has been found that increased levels of antibodies against EBV and HHV-6 correlate with the severity of long COVID.

This panel measures antibodies against six different viruses (EBV, CMV, HSV-1, HSV-2, HHV-6, VZV) that are involved in different inflammatory autoimmune diseases, chronic fatigue syndrome or myalgic encephalitis, neurodegenerative disorders such as Alzheimer’s and Parkinson’s, and neurological disorders such as Guillain-Barré syndrome and multiple sclerosis. Reactivation of these viruses is a major driver in increasing the severity of symptoms in patients with COVID-19. The test confirms immunological memory against Varicella zoster (VZV), the causative agent for shingles.

This panel measures antibodies against seven different viruses (EBV, CMV, HSV-1, HSV-2, HHV-6, VZV, measles) that are involved in different inflammatory autoimmune diseases, chronic fatigue syndrome or myalgic encephalitis, neurodegenerative disorders such as Alzheimer’s and Parkinson’s, and neurological disorders such as Guillain-Barré syndrome and multiple sclerosis. Reactivation of these viruses is a major driver in increasing the severity of symptoms in patients with COVID-19. The test confirms immunological memory against Varicella zoster (VZV), the causative agent for shingles, and against Rubeola, the causative agent for measles.

This panel detects the possible role of three viruses in a variety of inflammatory and autoimmune disorders.